List of Contents

Vascular Grafts Market Size, Share, and Trends 2024 to 2034

The global vascular grafts market size was USD 5.68 billion in 2023, estimated at USD 5.98 billion in 2024 and is anticipated to reach around USD 9.88 billion by 2034, expanding at a CAGR of 5% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 1758
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Vascular Grafts Market 

5.1. COVID-19 Landscape: Vascular Grafts Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Vascular Grafts Market, By Product

8.1. Vascular Grafts Market, by Product Type, 2024-2034

8.1.1. Vascular Grafts for Aorta Disease

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Peripheral Vascular Grafts 

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Endovascular Stent Grafts

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Coronary Artery By-Pass Grafts

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Vascular Grafts Market, By End Use

9.1. Vascular Grafts Market, by End Use, 2024-2034

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Ambulatory Surgical Centers

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Vascular Grafts Market, By Application Type 

10.1. Vascular Grafts Market, by Application Type, 2024-2034

10.1.1. Cardiac Aneurysm

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Kidney Failure

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Vascular Occlusion

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Coronary Artery Disease

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Vascular Grafts Market, By Raw Material Type 

11.1. Vascular Grafts Market, by Raw Material Type, 2024-2034

11.1.1. Polyester Vascular Grafts

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Polytetrafluoroethylene Vascular Grafts

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Polyurethane Vascular Grafts

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Biological Material Based Vascular Grafts

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Human Saphenous and Umbilical Veins

11.1.5.1. Market Revenue and Forecast (2021-2034)

11.1.6. Tissue Engineered Materials

11.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Vascular Grafts Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.2. Market Revenue and Forecast, by End Use (2021-2034)

12.1.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.1.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.5.2. Market Revenue and Forecast, by End Use (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.6.2. Market Revenue and Forecast, by End Use (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.2. Market Revenue and Forecast, by End Use (2021-2034)

12.2.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.5.2. Market Revenue and Forecast, by End Use (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.6.2. Market Revenue and Forecast, by End Use (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.7.2. Market Revenue and Forecast, by End Use (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.8.2. Market Revenue and Forecast, by End Use (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.2. Market Revenue and Forecast, by End Use (2021-2034)

12.3.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.5.2. Market Revenue and Forecast, by End Use (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.6.2. Market Revenue and Forecast, by End Use (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.7.2. Market Revenue and Forecast, by End Use (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.8.2. Market Revenue and Forecast, by End Use (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.2. Market Revenue and Forecast, by End Use (2021-2034)

12.4.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.5.2. Market Revenue and Forecast, by End Use (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.6.2. Market Revenue and Forecast, by End Use (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.7.2. Market Revenue and Forecast, by End Use (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.8.2. Market Revenue and Forecast, by End Use (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.2. Market Revenue and Forecast, by End Use (2021-2034)

12.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.5.2. Market Revenue and Forecast, by End Use (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.6.2. Market Revenue and Forecast, by End Use (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2021-2034)

Chapter 13. Company Profiles

13.1. Getinge AB

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Medtronic PLC

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. LeMaitre vascular Inc

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. WL gore and associates

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. terumo corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Shanghai suokang medical implants Co limited

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Cook Medical

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client